AP NEWS

Global Glioma Therapeutics Market Analysis & Trends 2015-2018 & Industry Forecast to 2027 Featuring F.Hoffmann-La Roche, Merck Sharp & Dohme, Mylan, NextSource Biotechnology & Novartis - ResearchAndMarkets.com

January 31, 2019

DUBLIN--(BUSINESS WIRE)--Jan 31, 2019--The “Global Glioma Therapeutics Market Analysis & Trends - Industry Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Glioma Therapeutics Market is poised to grow strong during the forecast period 2017 to 2027.

Some of the prominent trends that the market is witnessing include Advances in Glioblastoma Multiforme Treatment, Rise in Patient Population and Expedited Drug Discovery Process and Decrease in development of drug cost.

Based on Product, the market is categorized into Small molecules and Biologics.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies for the existing players, new entrants and the future investors.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview 3.1 Current Trends 3.1.1 Advances in Glioblastoma Multiforme Treatment 3.1.2 Rise in Patient Population and Expedited Drug Discovery Process 3.1.3 Decrease in development of drug cost 3.1.4 Growth Opportunities/Investment Opportunities 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness

4 Glioma Therapeutics Market, By Product 4.1 Small molecules 4.2 Biologics

5 Glioma Therapeutics Market, By Geography

6 Key Player Activities 6.1 Mergers & Acquisitions 6.2 Partnerships, Joint Ventures, Collaborations and Agreements 6.3 Product Launch & Expansions 6.4 Other Activities

7 Leading Companies

F.Hoffmann-La Roche Merck Sharp & Dohme Mylan NextSource Biotechnology Novartis

For more information about this report visit https://www.researchandmarkets.com/research/mbj9wt/global_glioma?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190131005571/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Brain Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/31/2019 10:10 AM/DISC: 01/31/2019 10:10 AM

http://www.businesswire.com/news/home/20190131005571/en

AP RADIO
Update hourly